We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Renalytix Plc | LSE:RENX | London | Ordinary Share | GB00BYWL4Y04 | ORD 0.25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.00 | -3.64% | 26.50 | 26.00 | 27.00 | 27.50 | 26.50 | 27.50 | 105,921 | 15:21:37 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Services, Nec | 3.4M | -46.22M | -0.4626 | -0.57 | 26.48M |
From Apr 2019 to Apr 2024
TIDMRENX TIDMEKF
RNS Number : 5675N
Renalytix AI PLC
21 January 2019
Renalytix AI plc
("Renalytix" or the "Company")
Clarification re. lock-up restrictions for Distribution Shares
This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the "Distribution Shares").
Holders of Distribution Shares are reminded that these shares remain subject to a lock-up restriction until 22 April 2019. To avoid settlement issues and potentially having to repurchase such shares in the market, such persons should therefore avoid attempting to sell Distribution Shares until Tuesday, 23 April 2019 or afterwards.
For further information, please contact:
Hot Features
Premium
Renalytix AI plc www.renalytixai.com
James McCullough, CEO Via Walbrook PR or Tel: +1 646
397 3970
N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000
Aubrey Powell / James White / George Tzimas (Corporate
Finance)
Tom Salvesen / Mia Gardner (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or renalytix@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391
303
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCLLFLRLAIIFIA
(END) Dow Jones Newswires
January 21, 2019 02:00 ET (07:00 GMT)
1 Year Renalytix Chart |
1 Month Renalytix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
